Shree Ganesh Bio

{
  "main_header": {
    "sid": 999946,
    "name": "Shree Ganesh Bio",
    "stock_name": "Shree Ganesh Bio",
    "full_name": "Shree Ganesh Biotech India Ltd",
    "name_url": "stocks-analysis/shree-ganesh-bio",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.66",
    "chg": 0.01,
    "chgp": "1.54%",
    "dir": 1,
    "prev_price": "0.65",
    "mcapval": "26.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539470,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 61,
    "indexname": "",
    "isin": "INE051N01026",
    "curr_date": "Feb 04",
    "curr_time": "",
    "bse_nse_vol": "8.18 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 04, 2026",
    "traded_date_str": "2026 02 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shree-ganesh-bio-999946-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Shree Ganesh Biotech India Ltd Gains 1.61%: 2 Key Factors Shaping the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-gains-161-2-key-factors-shaping-the-week-3812845",
        "imagepath": "",
        "date": "2026-01-31 14:01:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 27:</strong> Stock opens at Rs.0.61, declines 1.61% amid cautious sentiment</p>\n                    <p><strong>Jan 28:</strong> Sharp rebound with 6.56% gain to Rs.0.65 on increased volume</p>\n                    <p><strong>Jan 29:</strong> Quarterly results reveal revenue collapse and mounting losses, stock falls 4.62%</p>\n                    <p><strong>Jan 30:</strong> Flat quarterly performance reported, stock recovers 1.61% to close at Rs.0.63</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.0.62</div></div>\n                    <div class=\"stat-it..."
      },
      {
        "title": "Shree Ganesh Biotech India Ltd Reports Flat Quarterly Performance Amidst Lingering Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-ltd-reports-flat-quarterly-performance-amidst-lingering-sector-challenges-3810523",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShreeGaneshBiot_fintrenddot_3810523.png",
        "date": "2026-01-30 08:00:29",
        "description": "Shree Ganesh Biotech India Ltd has reported a flat financial performance for the quarter ended December 2025, signalling a pause in its previously negative trend. Despite a modest improvement in profitability over the nine-month period, the company continues to face operational challenges, particularly in debtor management and revenue growth, which have weighed on investor sentiment and share price performance."
      },
      {
        "title": "Are Shree Ganesh Biotech India Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-shree-ganesh-biotech-india-ltd-latest-results-good-or-bad-3810105",
        "imagepath": "",
        "date": "2026-01-29 19:24:04",
        "description": "The latest financial results for Shree Ganesh Biotech India Ltd indicate significant operational challenges. In the quarter ended September 2025, the company reported net sales of ₹0.77 crores, which reflects a substantial decline of 44.20% sequentially and marks the fourth consecutive quarter of revenue contraction. This downward trend is alarming, especially considering the company had previously reached net sales of ₹14.41 crores in December 2024.\n\nThe operational performance has also been concerning, with an operating loss of ₹0.39 crores, resulting in a negative operating margin of 50.65%. This is a stark contrast to the marginal operating margin of 1.01% achieved in the same quarter last year. The net profit for the quarter was merely ₹0.01 crores, representing a dramatic decline of 96.97% quarter-over-quarter and 96.88% year-over-year.\n\nThe company’s reliance on other income, which contributed ₹0.41 ..."
      },
      {
        "title": "Shree Ganesh Biotech India Q2 FY26: Revenue Collapse Deepens as Operating Losses Mount",
        "link": "https://www.marketsmojo.com/news/result-analysis/shree-ganesh-biotech-india-q2-fy26-revenue-collapse-deepens-as-operating-losses-mount-3810017",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ShreeGaneshBiot_quaterlyResult_3810017.png",
        "date": "2026-01-29 18:02:46",
        "description": "Shree Ganesh Biotech India Ltd. reported a net profit of just ₹0.01 crores for Q2 FY26, representing a staggering decline of 96.97% quarter-on-quarter and 96.88% year-on-year. The micro-cap pharmaceutical company, with a market capitalisation of ₹26.00 crores, continues to struggle with severe revenue contraction and mounting operational challenges. The stock has plunged 34.04% over the past year, closing at ₹0.62 on January 29, 2026, trading 46.09% below its 52-week high of ₹1.15."
      },
      {
        "title": "When is the next results date for Shree Ganesh Biotech India Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-shree-ganesh-biotech-india-ltd-3797118",
        "imagepath": "",
        "date": "2026-01-20 23:16:30",
        "description": "The next results date for Shree Ganesh Biotech India Ltd is scheduled for January 29, 2026...."
      },
      {
        "title": "Shree Ganesh Biotech India Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shree-ganesh-biotech-india-ltd-is-rated-strong-sell-3771032",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ShreeGaneshBiot_mojoScore_3771032.png",
        "date": "2025-12-26 15:13:06",
        "description": "Shree Ganesh Biotech India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Aug 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Shree Ganesh Bio Sees Revision in Market Evaluation Amidst Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shree-ganesh-bio-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3750615",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ShreeGaneshBio_mojoScore_3750615.png",
        "date": "2025-12-08 10:10:34",
        "description": "Shree Ganesh Bio, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation metrics. This shift reflects ongoing challenges in the company’s financial performance, valuation concerns, and technical indicators, underscoring the difficulties faced by the firm in the current market environment."
      },
      {
        "title": "Shree Ganesh Biotech India Falls to 52-Week Low of Rs.0.58 Amidst Weak Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-stock-falls-to-52-week-low-of-rs058-3738519",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ShreeGaneshBiot_priceRelatedfactors_3738519.png",
        "date": "2025-12-01 11:25:06",
        "description": "Shree Ganesh Biotech India has reached a new 52-week low of Rs.0.58, marking a significant decline in its stock price amid subdued financial performance and challenging market conditions within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Shree Ganesh Biotech India Stock Hits 52-Week Low at Rs.0.58",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-biotech-india-stock-hits-52-week-low-amidst-weak-financial-metrics-3738522",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ShreeGaneshBiot_priceRelatedfactors_3738522.png",
        "date": "2025-12-01 11:25:06",
        "description": "Shares of Shree Ganesh Biotech India have reached a new 52-week low of Rs.0.58, marking a significant decline in the stock’s valuation amid a challenging year for the company within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 142,
    "sid": "999946",
    "stock_news_url": "https://www.marketsmojo.com/news/shree-ganesh-biotech-india-999946"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015",
      "datetime": "29-Jan-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "29-Jan-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 29Th January 2026.",
      "datetime": "29-Jan-2026",
      "details": "Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Thursday 29th January 2026 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and nine months ended as on 31st December 2025. The board meeting commenced at 03:30 PM and concluded at 04:00 PM Please take the above intimation in your records. Thanking You.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Biotech India Ltd has announced <strong>1:10</strong> stock split, ex-date: 10 Feb 22",
          "dt": "2022-02-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Biotech India Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 27 Apr 22",
          "dt": "2022-04-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Shree Ganesh Biotech India Ltd Gains 1.61%: 2 Key Factors Shaping the Week

2026-01-31 14:01:01

Key Events This Week

Jan 27: Stock opens at Rs.0.61, declines 1.61% amid cautious sentiment

Jan 28: Sharp rebound with 6.56% gain to Rs.0.65 on increased volume

Jan 29: Quarterly results reveal revenue collapse and mounting losses, stock falls 4.62%

Jan 30: Flat quarterly performance reported, stock recovers 1.61% to close at Rs.0.63

Week Open

Rs.0.62

Read full news article

Shree Ganesh Biotech India Ltd Reports Flat Quarterly Performance Amidst Lingering Sector Challenges

2026-01-30 08:00:29

Shree Ganesh Biotech India Ltd has reported a flat financial performance for the quarter ended December 2025, signalling a pause in its previously negative trend. Despite a modest improvement in profitability over the nine-month period, the company continues to face operational challenges, particularly in debtor management and revenue growth, which have weighed on investor sentiment and share price performance.

Read full news article

Are Shree Ganesh Biotech India Ltd latest results good or bad?

2026-01-29 19:24:04

The latest financial results for Shree Ganesh Biotech India Ltd indicate significant operational challenges. In the quarter ended September 2025, the company reported net sales of ₹0.77 crores, which reflects a substantial decline of 44.20% sequentially and marks the fourth consecutive quarter of revenue contraction. This downward trend is alarming, especially considering the company had previously reached net sales of ₹14.41 crores in December 2024. The operational performance has also been concerning, with an operating loss of ₹0.39 crores, resulting in a negative operating margin of 50.65%. This is a stark contrast to the marginal operating margin of 1.01% achieved in the same quarter last year. The net profit for the quarter was merely ₹0.01 crores, representing a dramatic decline of 96.97% quarter-over-quarter and 96.88% year-over-year. The company’s reliance on other income, which contributed ₹0.41 ...

Read full news article

Shree Ganesh Biotech India Q2 FY26: Revenue Collapse Deepens as Operating Losses Mount

2026-01-29 18:02:46

Shree Ganesh Biotech India Ltd. reported a net profit of just ₹0.01 crores for Q2 FY26, representing a staggering decline of 96.97% quarter-on-quarter and 96.88% year-on-year. The micro-cap pharmaceutical company, with a market capitalisation of ₹26.00 crores, continues to struggle with severe revenue contraction and mounting operational challenges. The stock has plunged 34.04% over the past year, closing at ₹0.62 on January 29, 2026, trading 46.09% below its 52-week high of ₹1.15.

Read full news article

When is the next results date for Shree Ganesh Biotech India Ltd?

2026-01-20 23:16:30

The next results date for Shree Ganesh Biotech India Ltd is scheduled for January 29, 2026....

Read full news article

Shree Ganesh Biotech India Ltd is Rated Strong Sell

2025-12-26 15:13:06

Shree Ganesh Biotech India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Aug 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and prospects.

Read full news article

Shree Ganesh Bio Sees Revision in Market Evaluation Amidst Challenging Financials

2025-12-08 10:10:34

Shree Ganesh Bio, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation metrics. This shift reflects ongoing challenges in the company’s financial performance, valuation concerns, and technical indicators, underscoring the difficulties faced by the firm in the current market environment.

Read full news article

Shree Ganesh Biotech India Falls to 52-Week Low of Rs.0.58 Amidst Weak Financial Metrics

2025-12-01 11:25:06

Shree Ganesh Biotech India has reached a new 52-week low of Rs.0.58, marking a significant decline in its stock price amid subdued financial performance and challenging market conditions within the Pharmaceuticals & Biotechnology sector.

Read full news article

Shree Ganesh Biotech India Stock Hits 52-Week Low at Rs.0.58

2025-12-01 11:25:06

Shares of Shree Ganesh Biotech India have reached a new 52-week low of Rs.0.58, marking a significant decline in the stock’s valuation amid a challenging year for the company within the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News